Nifty

:

25323.55

Sensex

:

82605.43

178.05 (0.71%)
575.45 (0.70%)

Login

Nifty
Sensex

:
:

25323.55
82605.43

178.05 (0.71%)
575.45 (0.70%)

Hester Biosciences Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

51/99

BSE: 524669 | NSE: HESTERBIO

Watchlist

NSE BSE

1721.10

15-Oct-2025

Open
High
Low
Previous Close

1720.3
1735
1717
1720.40

Volume
Traded Value (lacs)
52 Week High
52 Week Low

2510
4328925.2
2786.1
1242.95

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,466.50
39.01
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,667.05
0.41%
4.44

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.92
7.74
5.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.22
-2.32
3.91

PAT CAGR (%)

10 Years
5 Years
3 Years

3.66
-4.40
1.07

P:E (Median)

8 Years
5 Years
3 Years

50.72
54.41
55.31

P:BV (Average)

8 Years
5 Years
3 Years

6.97
6.50
5.47

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.62
27.36
26.99

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 63.49 73.47 -13.58% 76.67 72.87 5.21% 62.83 65.50 -4.08% 73.50 66.43 10.64%
Expenses 51.08 59.97 -14.82% 62.97 60.46 4.15% 53.81 53.94 -0.24% 58.77 54.44 7.95%
EBITDA 12.41 13.50 -8.07% 13.70 12.41 10.39% 9.01 11.57 -22.13% 14.73 11.99 22.85%
EBIDTM 19.55% 18.37% 17.87% 17.04% 14.35% 17.66% 20.04% 18.05%
Other Income 0.95 1.06 -10.38% 1.06 1.20 -11.67% 1.30 0.98 32.65% 1.35 1.22 10.66%
Interest 0.91 1.13 -19.47% 1.25 1.31 -4.58% 1.59 1.37 16.06% 1.40 1.48 -5.41%
Depreciation 2.16 2.12 1.89% 2.03 2.08 -2.40% 2.24 2.57 -12.84% 2.19 2.58 -15.12%
PBT 10.29 11.30 -8.94% 11.48 10.22 12.33% 6.49 8.61 -24.62% 12.48 9.16 36.24%
Tax 2.45 2.87 -14.63% 1.85 2.79 -33.69% 2.05 2.14 -4.21% 3.15 2.38 32.35%
PAT 7.84 8.43 -7.00% 9.63 7.43 29.61% 4.44 6.47 -31.38% 9.34 6.78 37.76%
PATM 12.35% 11.48% 12.57% 10.20% 7.07% 9.88% 12.70% 10.21%
EPS 9.22 9.92 -7.06% 11.34 8.74 29.75% 5.22 7.62 -31.50% 10.98 7.98 37.59%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 84.10 82.27 2.22% 81.92 79.25 3.37% 63.22 66.98 -5.61% 83.69 70.45 18.79%
Expenses 61.29 64.62 -5.15% 62.74 63.33 -0.93% 58.16 56.83 2.34% 64.53 57.24 12.74%
EBITDA 22.81 17.65 29.24% 19.18 15.92 20.48% 5.06 10.16 -50.20% 19.16 13.22 44.93%
EBIDTM 27.13% 21.45% 23.41% 20.09% 8.01% 15.16% 22.89% 18.76%
Other Income 2.32 1.23 88.62% -6.95 4.15 - 7.81 0.99 688.89% 1.84 4.36 -57.80%
Interest 1.81 5.01 -63.87% 5.62 6.94 -19.02% -3.81 2.19 - 5.89 8.07 -27.01%
Depreciation 4.18 4.13 1.21% 4.18 3.74 11.76% 4.29 3.75 14.40% 4.20 4.28 -1.87%
PBT 19.14 9.73 96.71% 2.44 9.39 -74.01% 12.39 5.20 138.27% 10.91 5.21 109.40%
Tax 2.89 3.11 -7.07% 2.20 3.47 -36.60% 1.96 2.39 -17.99% 3.48 2.72 27.94%
PAT 16.25 6.63 145.10% 0.23 5.91 -96.11% 10.43 2.81 271.17% 7.44 2.49 198.80%
PATM 19.32% 8.05% 0.28% 7.46% 16.50% 4.20% 8.88% 3.54%
EPS 19.33 7.45 159.46% 1.52 5.82 -73.88% 13.71 4.68 192.95% 9.64 4.80 100.83%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 276.49 286.47 285.15 254.00 219.35 208.48 169.43 171.19 134.79 123.28 100.89 Net Sales Growth -0.64% 0.46% 12.26% 15.80% 5.21% 23.05% -1.03% 27.00% 9.34% 22.19% Cost Of Goods Sold 90.19 93.65 99.64 79.88 63.84 53.39 29.24 29.21 23.31 29.89 19.75 Gross Profit 186.30 192.81 185.51 174.12 155.51 155.08 140.19 141.97 111.47 93.39 81.14 GP Margin 67.38% 67.31% 65.06% 68.55% 70.90% 74.39% 82.74% 82.93% 82.70% 75.75% 80.42% Total Expenditure 226.63 235.52 238.30 199.32 158.78 136.48 116.70 103.42 85.19 82.21 67.50 Power & Fuel Cost - 10.12 12.34 9.95 8.74 6.93 7.29 7.08 5.84 5.31 5.81 % Of Sales - 3.53% 4.33% 3.92% 3.98% 3.32% 4.30% 4.14% 4.33% 4.31% 5.76% Employee Cost - 54.76 56.72 47.92 39.12 33.45 37.16 26.74 22.29 18.32 15.44 % Of Sales - 19.12% 19.89% 18.87% 17.83% 16.04% 21.93% 15.62% 16.54% 14.86% 15.30% Manufacturing Exp. - 15.62 15.20 10.54 10.17 10.79 11.31 10.95 9.24 6.97 7.85 % Of Sales - 5.45% 5.33% 4.15% 4.64% 5.18% 6.68% 6.40% 6.86% 5.65% 7.78% General & Admin Exp. - 26.01 24.92 21.60 14.50 13.24 16.34 11.77 12.92 11.35 10.23 % Of Sales - 9.08% 8.74% 8.50% 6.61% 6.35% 9.64% 6.88% 9.59% 9.21% 10.14% Selling & Distn. Exp. - 26.89 24.63 24.68 17.16 13.68 11.42 16.02 9.09 8.15 6.77 % Of Sales - 9.39% 8.64% 9.72% 7.82% 6.56% 6.74% 9.36% 6.74% 6.61% 6.71% Miscellaneous Exp. - 8.46 4.86 4.76 5.26 5.00 3.95 1.65 2.50 2.22 6.77 % Of Sales - 2.95% 1.70% 1.87% 2.40% 2.40% 2.33% 0.96% 1.85% 1.80% 1.63% EBITDA 49.85 50.95 46.85 54.68 60.57 72.00 52.73 67.77 49.60 41.07 33.39 EBITDA Margin 18.03% 17.79% 16.43% 21.53% 27.61% 34.54% 31.12% 39.59% 36.80% 33.31% 33.10% Other Income 4.66 4.76 4.75 5.53 4.66 1.65 2.93 3.10 1.88 0.73 0.87 Interest 5.15 5.37 5.09 6.50 2.47 3.95 5.03 3.54 2.32 3.21 3.69 Depreciation 8.62 8.58 9.78 9.79 9.50 9.63 9.38 7.57 5.45 5.51 5.73 PBT 40.74 41.76 36.73 43.92 53.26 60.06 41.23 59.75 43.71 33.09 24.85 Tax 9.50 9.92 9.57 11.58 13.74 14.88 10.01 15.90 13.15 8.15 5.63 Tax Rate 23.32% 23.75% 26.05% 26.37% 25.80% 27.16% 24.28% 26.61% 30.08% 24.63% 22.66% PAT 31.25 31.84 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 PAT before Minority Interest 31.25 31.84 27.16 32.34 39.52 39.90 31.22 43.85 30.56 24.94 19.22 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.30% 11.11% 9.52% 12.73% 18.02% 19.14% 18.43% 25.61% 22.67% 20.23% 19.05% PAT Growth 7.35% 17.23% -16.02% -18.17% -0.95% 27.80% -28.80% 43.49% 22.53% 29.76% EPS 36.76 37.46 31.95 38.05 46.49 46.94 36.73 51.59 35.95 29.34 22.61

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 312.93 311.10 304.55 266.09 235.01 214.33 183.27 178.07 135.94 123.11 100.89 Net Sales Growth 4.68% 2.15% 14.45% 13.22% 9.65% 16.95% 2.92% 30.99% 10.42% 22.02% Cost Of Goods Sold 87.34 88.33 95.88 77.49 64.85 50.23 27.98 28.47 23.31 28.45 19.75 Gross Profit 225.59 222.78 208.67 188.60 170.15 164.11 155.29 149.60 112.63 94.65 81.14 GP Margin 72.09% 71.61% 68.52% 70.88% 72.40% 76.57% 84.73% 84.01% 82.85% 76.88% 80.42% Total Expenditure 246.72 250.05 251.38 215.69 175.02 145.67 127.87 110.03 88.68 82.09 67.50 Power & Fuel Cost - 13.98 15.30 12.74 10.28 7.57 8.13 7.83 6.37 5.59 5.81 % Of Sales - 4.49% 5.02% 4.79% 4.37% 3.53% 4.44% 4.40% 4.69% 4.54% 5.76% Employee Cost - 62.42 64.13 56.02 45.33 38.92 40.65 28.93 23.24 18.32 15.44 % Of Sales - 20.06% 21.06% 21.05% 19.29% 18.16% 22.18% 16.25% 17.10% 14.88% 15.30% Manufacturing Exp. - 18.05 17.13 12.67 11.51 11.60 11.98 11.34 9.45 7.06 7.85 % Of Sales - 5.80% 5.62% 4.76% 4.90% 5.41% 6.54% 6.37% 6.95% 5.73% 7.78% General & Admin Exp. - 29.64 27.17 24.89 19.20 15.29 13.47 13.72 13.81 11.47 10.23 % Of Sales - 9.53% 8.92% 9.35% 8.17% 7.13% 7.35% 7.70% 10.16% 9.32% 10.14% Selling & Distn. Exp. - 28.28 25.60 26.34 17.31 14.73 18.97 16.77 9.11 8.15 6.77 % Of Sales - 9.09% 8.41% 9.90% 7.37% 6.87% 10.35% 9.42% 6.70% 6.62% 6.71% Miscellaneous Exp. - 9.36 6.18 5.54 6.53 7.34 6.69 2.98 3.40 3.05 6.77 % Of Sales - 3.01% 2.03% 2.08% 2.78% 3.42% 3.65% 1.67% 2.50% 2.48% 1.63% EBITDA 66.21 61.05 53.17 50.40 59.99 68.66 55.40 68.04 47.26 41.02 33.39 EBITDA Margin 21.16% 19.62% 17.46% 18.94% 25.53% 32.03% 30.23% 38.21% 34.77% 33.32% 33.10% Other Income 5.02 3.92 11.13 15.36 13.74 4.68 6.37 7.21 2.55 0.42 0.88 Interest 9.51 12.70 19.77 9.32 4.06 6.60 7.37 6.63 4.04 3.50 3.72 Depreciation 16.85 16.80 17.17 20.70 16.58 13.31 13.07 11.76 9.66 7.00 5.75 PBT 44.88 35.47 27.34 35.74 53.08 53.42 41.33 56.86 36.12 30.93 24.81 Tax 10.53 10.74 10.79 12.12 14.02 15.40 10.32 16.16 13.05 8.15 5.63 Tax Rate 23.46% 30.28% 39.47% 33.91% 26.41% 30.74% 24.97% 28.42% 36.13% 26.35% 22.69% PAT 34.35 27.49 18.89 26.63 39.32 34.43 29.17 41.56 25.62 23.55 19.19 PAT before Minority Interest 33.31 28.83 21.17 28.04 39.48 34.70 31.00 40.69 23.07 22.79 19.18 Minority Interest -1.04 -1.34 -2.28 -1.41 -0.16 -0.27 -1.83 0.87 2.55 0.76 0.01 PAT Margin 10.98% 8.84% 6.20% 10.01% 16.73% 16.06% 15.92% 23.34% 18.85% 19.13% 19.02% PAT Growth 92.54% 45.53% -29.06% -32.27% 14.20% 18.03% -29.81% 62.22% 8.79% 22.72% EPS 40.41 32.34 22.22 31.33 46.26 40.51 34.32 48.89 30.14 27.71 22.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 339.09 312.71 292.38 268.43 237.58 203.08 179.44 146.08 122.09 100.32 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 330.58 304.20 283.88 259.93 229.07 194.57 170.93 137.57 113.58 91.81 Non-Current Liabilities 110.21 139.11 116.96 81.17 9.79 15.89 21.51 21.98 22.36 21.05 Secured Loans 51.31 79.07 83.40 73.25 2.68 7.45 11.37 14.61 18.66 12.87 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.38 2.26 1.72 1.08 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 96.70 97.72 136.47 74.84 34.65 58.22 39.30 42.43 33.99 37.45 Trade Payables 32.53 29.68 28.71 11.03 14.03 13.61 8.05 7.85 7.47 5.84 Other Current Liabilities 30.86 35.58 46.59 29.34 15.11 12.37 10.05 9.33 7.82 8.55 Short Term Borrowings 28.64 29.79 57.34 33.29 1.71 31.80 20.94 24.19 17.51 21.04 Short Term Provisions 4.67 2.67 3.83 1.18 3.81 0.44 0.26 1.06 1.18 2.02 Total Liabilities 546.00 549.54 545.81 424.44 282.02 277.19 240.25 210.49 178.44 158.82 Net Block 105.46 103.46 108.22 84.31 86.69 96.76 100.81 66.74 60.85 61.57 Gross Block 212.38 203.62 199.00 171.17 164.64 166.61 161.97 120.89 109.55 105.07 Accumulated Depreciation 106.92 100.16 90.78 86.86 77.95 69.85 61.02 54.15 48.70 43.50 Non Current Assets 360.76 345.13 329.77 257.97 142.41 154.01 140.84 121.36 103.63 91.64 Capital Work in Progress 182.70 171.40 148.61 81.91 3.72 0.87 0.42 30.47 21.29 10.47 Non Current Investment 64.69 64.69 64.69 64.69 43.88 40.67 28.22 14.48 8.60 8.67 Long Term Loans & Adv. 6.30 4.85 6.83 24.20 5.32 11.83 9.81 9.59 12.41 10.93 Other Non Current Assets 1.61 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 Current Assets 185.24 204.41 216.05 166.47 139.61 123.18 99.40 89.13 74.81 67.18 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 58.51 68.53 79.22 70.73 57.01 60.43 48.50 38.70 33.07 33.62 Sundry Debtors 80.59 85.78 82.36 56.92 45.55 44.76 32.67 31.94 26.71 26.24 Cash & Bank 2.18 4.96 5.96 1.98 1.24 5.19 2.49 11.95 11.48 5.26 Other Current Assets 43.96 5.36 5.45 2.83 35.80 12.80 15.74 6.54 3.56 2.07 Short Term Loans & Adv. 36.80 39.78 43.06 34.01 29.50 11.84 12.95 5.69 3.30 2.07 Net Current Assets 88.53 106.69 79.58 91.64 104.96 64.96 60.10 46.70 40.82 29.73 Total Assets 546.00 549.54 545.82 424.44 282.02 277.19 240.24 210.49 178.44 158.82

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 314.25 291.79 279.73 259.99 228.31 201.07 177.46 140.63 121.95 101.71 Share Capital 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 8.51 Total Reserves 305.75 283.29 271.22 251.48 219.80 192.56 168.95 132.13 113.44 93.20 Non-Current Liabilities 201.54 254.00 232.72 197.87 113.72 96.64 69.64 44.41 48.32 41.28 Secured Loans 133.37 182.09 184.85 164.54 82.84 76.48 58.35 36.54 44.62 33.09 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.75 2.53 1.93 1.27 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 125.18 105.47 148.70 96.90 61.37 83.46 48.66 54.63 38.01 38.20 Trade Payables 29.42 25.86 29.98 18.02 28.09 20.02 8.75 7.90 7.47 5.84 Other Current Liabilities 61.14 45.05 55.96 42.81 22.52 30.44 17.15 20.26 11.04 9.30 Short Term Borrowings 29.58 31.35 58.86 34.84 3.28 32.54 22.50 25.41 18.32 21.04 Short Term Provisions 5.05 3.22 3.90 1.22 7.48 0.46 0.26 1.07 1.18 2.02 Total Liabilities 653.37 662.34 669.97 562.17 411.05 386.59 299.46 244.04 212.88 185.84 Net Block 233.31 240.11 259.37 237.17 132.76 142.54 144.82 110.22 102.62 64.63 Gross Block 390.00 382.04 385.80 348.16 228.12 226.04 215.94 170.22 152.95 108.25 Accumulated Depreciation 156.69 141.93 126.43 110.99 95.36 83.50 70.98 60.00 50.33 43.62 Non Current Assets 458.21 447.73 442.37 367.40 249.54 227.29 157.80 145.59 132.91 111.63 Capital Work in Progress 182.70 171.40 148.61 81.91 109.17 74.15 7.05 31.81 21.29 36.46 Non Current Investment 34.05 29.93 25.30 21.24 0.00 0.00 0.00 0.00 0.00 0.07 Long Term Loans & Adv. 6.54 5.55 7.67 24.22 4.82 6.74 4.34 3.48 8.52 10.47 Other Non Current Assets 1.61 0.74 1.43 2.86 2.80 3.87 1.58 0.08 0.47 0.00 Current Assets 195.17 214.62 227.59 194.76 161.50 159.31 141.66 98.45 79.97 74.20 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 70.38 75.58 84.81 75.38 62.22 63.97 50.79 39.76 33.41 33.62 Sundry Debtors 73.18 78.64 79.63 55.28 49.21 58.44 32.87 32.29 26.53 26.24 Cash & Bank 7.22 15.30 14.82 25.20 21.27 23.53 41.05 13.39 11.48 5.28 Other Current Assets 44.39 5.81 6.02 5.20 28.80 13.37 16.95 13.01 8.54 9.05 Short Term Loans & Adv. 36.88 39.27 42.31 33.70 26.24 8.19 11.32 8.95 5.06 2.49 Net Current Assets 69.99 109.14 78.90 97.87 100.14 75.84 92.99 43.82 41.95 36.00 Total Assets 653.38 662.35 669.96 562.16 411.04 386.60 299.46 244.04 212.88 185.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 63.97 42.86 33.36 15.90 41.10 25.82 36.19 32.28 27.55 18.64 PBT 41.76 36.73 43.92 53.26 54.78 41.23 59.75 43.71 33.09 24.85 Adjustment 15.82 13.32 14.55 11.70 19.61 12.25 8.50 7.34 8.74 9.31 Changes in Working Capital 16.31 3.84 -17.05 -32.61 -19.80 -16.31 -16.47 -9.37 -7.22 -9.54 Cash after chg. in Working capital 73.89 53.89 41.43 32.34 54.59 37.17 51.78 41.67 34.61 24.62 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -9.92 -11.03 -8.06 -16.44 -13.49 -11.35 -15.58 -9.39 -7.06 -5.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -19.04 -20.59 -71.96 -110.58 -3.72 -21.33 -24.70 -26.32 -15.49 -5.68 Net Fixed Assets -20.06 -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 Net Investments 0.00 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 Others 1.02 6.82 22.57 -5.05 0.37 -3.79 0.07 0.08 -0.26 0.98 Cash from Financing Activity -46.35 -24.12 41.38 94.96 -41.33 -1.39 -20.29 -6.24 -5.60 -11.92 Net Cash Inflow / Outflow -1.42 -1.85 2.77 0.28 -3.95 3.10 -8.80 -0.28 6.46 1.04 Opening Cash & Equivalents 1.97 3.81 1.53 1.24 5.19 2.09 10.89 11.17 4.71 3.92 Closing Cash & Equivalent 0.55 1.97 4.30 1.53 1.24 5.19 2.09 10.89 11.17 4.96

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 64.51 48.18 23.60 8.71 58.05 36.77 46.71 38.02 34.80 18.85 PBT 39.57 31.95 40.15 53.50 50.10 41.33 56.86 36.12 30.93 24.81 Adjustment 26.47 24.22 12.39 11.10 20.34 20.13 17.92 13.63 10.86 9.38 Changes in Working Capital 9.95 3.67 -20.84 -38.78 1.54 -13.75 -12.26 -2.31 0.11 -9.37 Cash after chg. in Working capital 75.98 59.85 31.70 25.82 71.99 47.71 62.52 47.44 41.90 24.82 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -11.47 -11.67 -8.11 -17.11 -13.94 -10.94 -15.81 -9.41 -7.06 -5.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 0.00 Cash From Investing Activity -19.00 -22.61 -77.00 -116.59 -38.37 -74.47 -21.73 -25.83 -30.19 -13.30 Net Fixed Assets -20.06 -27.41 -94.53 -84.72 -0.88 -5.09 -11.03 -20.52 -15.30 -6.87 Net Investments 0.00 0.00 0.00 -20.81 -3.21 -12.45 -13.74 -5.88 0.07 0.21 Others 1.06 4.80 17.53 -11.06 -34.28 -56.93 3.04 0.57 -14.96 -6.64 Cash from Financing Activity -51.72 -26.09 41.76 111.54 -18.22 18.74 2.65 -11.08 1.83 -6.68 Net Cash Inflow / Outflow -6.21 -0.52 -11.64 3.66 1.46 -18.96 27.63 1.12 6.45 -1.14 Opening Cash & Equivalents 12.31 12.67 24.75 21.27 23.53 40.65 12.33 11.18 4.73 6.12 Closing Cash & Equivalent 5.59 12.31 13.16 24.75 21.27 23.53 40.65 12.33 11.18 4.99

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 398.60 367.59 343.70 315.54 279.28 238.72 210.93 171.72 143.52 117.93 ROA 5.81% 4.96% 6.67% 11.19% 14.27% 12.07% 19.46% 15.71% 14.79% 12.85% ROE 9.77% 8.98% 11.53% 15.62% 18.11% 16.33% 26.94% 22.79% 22.43% 20.83% ROCE 10.59% 9.26% 11.91% 17.31% 23.28% 19.74% 31.15% 26.28% 24.16% 21.79% Fixed Asset Turnover 1.38 1.42 1.38 1.32 1.26 1.03 1.21 1.17 1.17 1.03 Receivable days 105.93 107.52 99.32 84.52 79.06 83.41 68.88 79.13 76.95 77.96 Inventory Days 80.88 94.48 106.93 105.37 102.81 117.33 92.96 96.84 96.91 111.14 Payable days 121.23 106.95 90.79 71.61 94.44 36.28 28.05 36.46 33.72 29.57 Cash Conversion Cycle 65.58 95.05 115.46 118.28 87.43 164.47 133.79 139.51 140.15 159.53 Total Debt/Equity 0.31 0.43 0.56 0.45 0.07 0.24 0.21 0.29 0.32 0.39 Interest Cover 8.78 8.21 7.76 22.58 14.88 9.19 17.87 19.88 11.31 7.74

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 369.41 343.00 328.82 305.61 268.38 236.36 208.61 165.32 143.35 119.56 ROA 4.38% 3.18% 4.55% 8.11% 8.70% 9.04% 14.97% 10.10% 11.43% 11.08% ROE 9.51% 7.41% 10.39% 16.17% 16.16% 16.38% 25.59% 17.57% 20.38% 20.56% ROCE 9.93% 9.59% 9.60% 14.12% 17.33% 16.53% 26.64% 20.20% 19.75% 18.98% Fixed Asset Turnover 0.81 0.79 0.73 0.82 0.95 0.83 0.92 0.84 0.96 1.00 Receivable days 89.02 94.77 91.87 80.50 91.49 90.92 66.77 78.70 76.80 77.96 Inventory Days 85.58 96.04 109.08 106.00 107.25 114.27 92.80 97.89 97.55 111.14 Payable days 114.21 106.28 113.04 129.73 174.82 42.10 27.25 33.70 33.48 29.56 Cash Conversion Cycle 60.38 84.54 87.91 56.77 23.92 163.09 132.33 142.89 140.87 159.54 Total Debt/Equity 0.66 0.82 0.96 0.86 0.46 0.60 0.51 0.49 0.54 0.58 Interest Cover 4.12 2.62 5.31 14.16 8.59 6.61 9.57 9.95 9.84 7.67

Top Investors:

kuntal hasmukhlal shah

darshna dinesh kapadia

manish jain (huf)

manish prataprai gandhi

jagrut prataprai gandhi

sandeep shantilal gala

investor education and protection fund (iepf)

Annual Reports:

News Update:

Hester Biosciences - Quarterly Results
1st Aug 2025, 12:23 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback